Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.80% Nasdaq Up0.97%

BioCryst Pharmaceuticals, Inc. (BCRX)

-NasdaqGS

1.71 Down 0.02(1.16%) May 17, 4:00PM EDT|After Hours : 1.73 Up 0.02 (1.17%) May 17, 6:04PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 3,554   4,101   5,761   4,210  
Cost of Revenue -   -   -   -  
Gross Profit 3,554   4,101   5,761   4,210  
Operating Expenses
Research Development7,411  11,090  12,072  12,777  
Selling General and Administrative1,382  1,929  1,591  1,609  
Non Recurring77  1,777  114   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (5,316) (10,695) (8,016) (10,176)
Income from Continuing Operations
Total Other Income/Expenses Net1,990  822  (518)(940)
Earnings Before Interest And Taxes(3,326)(9,873)(8,534)(11,116)
Interest Expense1,180  1,180  1,166  1,160  
Income Before Tax(4,506)(11,053)(9,700)(12,276)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(4,506)(11,053)(9,700)(12,276)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (4,506) (11,053) (9,700) (12,276)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (4,506) (11,053) (9,700) (12,276)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.